Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Plasma cell 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Breast Neoplasms 14Carcinoma, Non-Small-Cell Lung 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 4Melanoma 4Lung Neoplasms 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Acute 4Breast Diseases 4Thoracic Neoplasms 3Respiratory Tract Neoplasms 3Lung Diseases 3Bronchial Neoplasms 3Uveal Melanoma 2Sezary Syndrome 2Rectal Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Pinealoma 2Pancreatic Neoplasms 2Neoplasms, Glandular and Epithelial 2Neoplasms by Histologic Type 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

Cytarabine 16Arsenic Trioxide 11Tretinoin 10Methotrexate 10Cyclophosphamide 9Idarubicin 8Filgrastim 7Mercaptopurine 6Busulfan 6fludarabine phosphate 5Etoposide 5Vorinostat 4Topotecan 4Sorafenib 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Daunorubicin 4Clofarabine 4Granulocyte Colony-Stimulating Factor 3Gemtuzumab 3Azacitidine 3Antilymphocyte Serum 3romidepsin 2merphos 2lintuzumab 2entinostat 2Thiotepa 2Tacrolimus 2Mitoxantrone 2Lenalidomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Leukemia, Promyelocytic, Acute × entinostat × Clear all
NCT00313586 2017-02-02

Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
197 enrolled 8 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute

NCT00015925 2010-03-10

MS-275 in Treating Patients With Hematologic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡